Received Feb 11, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPIPV | DTAP + IPV (KINRIX) | GLAXOSMITHKLINE BIOLOGICALS | 5 | 93H32 | IM / LL |
| FLU3 | INFLUENZA (SEASONAL) (FLULAVAL) | GLAXOSMITHKLINE BIOLOGICALS | 4 | 4D255 | IM / RL |
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | 2 | Z014047 | IM / RL |
Patient seen in clinic on 02/02/2026, Kinrix administered to complete vaccines to enroll in Kindergarten. Vaccines later reviewed by another nurse and it was noted that Kinrix was administered outside the 4-6 yr. age recommendation. Nurse called CDC and local state immunization dept. for further recommendations. No adverse reaction noted.
developmental delay
None
None
none